148 related articles for article (PubMed ID: 21605943)
1. Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies.
Barnett GC; West CM; Coles CE; Pharoah PD; Talbot CJ; Elliott RM; Tanteles GA; Symonds RP; Wilkinson JS; Dunning AM; Burnet NG; Bentzen SM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1065-74. PubMed ID: 21605943
[TBL] [Abstract][Full Text] [Related]
2. The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity.
Barnett GC; Wilkinson JS; Moody AM; Wilson CB; Twyman N; Wishart GC; Burnet NG; Coles CE
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):662-73. PubMed ID: 21646002
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
[TBL] [Abstract][Full Text] [Related]
4. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
[TBL] [Abstract][Full Text] [Related]
5. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial.
Liss AL; Ben-David MA; Jagsi R; Hayman JA; Griffith KA; Moran JM; Marsh RB; Pierce LJ
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):96-102. PubMed ID: 24613813
[TBL] [Abstract][Full Text] [Related]
6. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
[TBL] [Abstract][Full Text] [Related]
7. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.
Dicuonzo S; Leonardi MC; Raimondi S; Corrao G; Bagnardi V; Gerardi MA; Morra A; Zerella MA; Zaffaroni M; Pansini F; Cattani F; Luraschi R; Fodor C; Veronesi P; Orecchia R; Rojas DP; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Jul; 23(7):1415-1428. PubMed ID: 33537865
[TBL] [Abstract][Full Text] [Related]
8. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
11. Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis.
Peterson D; Truong PT; Parpia S; Olivotto IA; Berrang T; Kim DH; Kong I; Germain I; Nichol A; Akra M; Roy I; Reed M; Fyles A; Trotter T; Perera F; Balkwill S; Lavertu S; Elliott E; Julian JA; Levine MN; Whelan TJ;
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):968-76. PubMed ID: 25832689
[TBL] [Abstract][Full Text] [Related]
12. [Acute skin toxicity in breast intensity modulated radiotherapy using field in field technique].
Blanchecotte J; Ruffier-Loubière A; Reynaud-Bougnoux A; Barillot I
Cancer Radiother; 2015 Apr; 19(2):82-8. PubMed ID: 25623257
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer : Results from a phase II trial.
Meng J; Huang W; Mei X; Yu X; Pan Z; Ma J; Ma X; Chen J; Guo X; Yang Z
Strahlenther Onkol; 2020 Sep; 196(9):764-770. PubMed ID: 32318767
[TBL] [Abstract][Full Text] [Related]
14. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
15. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique.
Hardee ME; Raza S; Becker SJ; Jozsef G; Lymberis SC; Hochman T; Goldberg JD; DeWyngaert KJ; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e415-23. PubMed ID: 22019349
[TBL] [Abstract][Full Text] [Related]
16. Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer.
Lewin AA; Derhagopian R; Saigal K; Panoff JE; Abitbol A; Wieczorek DJ; Mishra V; Reis I; Ferrell A; Moreno L; Takita C
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2104-10. PubMed ID: 21640490
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.
Quon H; Cheung PC; Loblaw DA; Morton G; Pang G; Szumacher E; Danjoux C; Choo R; Thomas G; Kiss A; Mamedov A; Deabreu A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):898-905. PubMed ID: 21237581
[TBL] [Abstract][Full Text] [Related]
18. The impact of skin washing with water and soap during breast irradiation: a randomized study.
Roy I; Fortin A; Larochelle M
Radiother Oncol; 2001 Mar; 58(3):333-9. PubMed ID: 11230896
[TBL] [Abstract][Full Text] [Related]
19. The Cambridge Breast Intensity-modulated Radiotherapy Trial: Comparison of Clinician- versus Patient-reported Outcomes.
Mukesh MB; Qian W; Wah Hak CC; Wilkinson JS; Barnett GC; Moody AM; Wilson C; Coles CE
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):354-64. PubMed ID: 27021931
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
